SamMobile has affiliate and sponsored partnerships. If you buy something through one of these links, we may earn a commission.
Here you will find the latest news and most recent developments on the Samsung Biologics, with regular updates and all the information you need.
Samsung has announced that it will spend around KRW 450 trillion (around $355 billion) on semiconductor and biopharmaceutical segments over the next five years. The company will also invest in next-generation technologies to stay ahead of its competitors. The South Korean tech chaebol has increased its investment by 30% compared to its previous five-year plan of […]
What do semiconductors and COVID-19 vaccines have in common? Nothing really, but Samsung Biologics reportedly wants to secure vaccine production orders as well as patented technologies from US-based pharmaceutical companies Pfizer and Moderna, and the Korean tech giant's semiconductor expansion plans in the USA might be used as leverage. President Moon Jae-in will attend the […]
Samsung Biologics announced earlier today that it has clinched a deal to manufacture a candidate treatment for the coronavirus illness. The biopharmaceutical arm of Samsung Group has signed a $362.2 million contract with the U.S. drug firm Vir Biotechnology. The company will start full-scale production of candidate COVID-19 treatment that is known to be quite powerful […]